4-955426-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032326.4(TMEM175):c.649G>A(p.Val217Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000344 in 1,614,138 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032326.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM175 | NM_032326.4 | c.649G>A | p.Val217Ile | missense_variant | 9/11 | ENST00000264771.9 | NP_115702.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM175 | ENST00000264771.9 | c.649G>A | p.Val217Ile | missense_variant | 9/11 | 1 | NM_032326.4 | ENSP00000264771.4 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000115 AC: 29AN: 251116Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135816
GnomAD4 exome AF: 0.000365 AC: 533AN: 1461790Hom.: 1 Cov.: 31 AF XY: 0.000355 AC XY: 258AN XY: 727206
GnomAD4 genome AF: 0.000151 AC: 23AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2024 | The c.649G>A (p.V217I) alteration is located in exon 9 (coding exon 8) of the TMEM175 gene. This alteration results from a G to A substitution at nucleotide position 649, causing the valine (V) at amino acid position 217 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at